FindTrial
Sign In

A clinical study of 'Yinjiang' I Decoction in the treatment of Histolytic Necrotizing Lymphadenitis

Treatment of Histolytic Necrotizing Lymphadenitis with 'Yinjiang' I Decoction: a Clinical Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17012565
Enrollment
Unknown
Registered
2017-09-04
Start date
2018-01-01
Completion date
Unknown
Last updated
2017-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Histolytic Necrotizing Lymphadenitis

Interventions

1:Modified 'Yinjiang' decoction based on zhen
2:"Yinjiang" decoction

Sponsors

Nanjing Integrated Traditional and Western Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. The patient was confirmed with Histolytic Necrotizing Lymphadenitis; 2. WBC 2.0*10^9/L to 10.0*10^9/L; NEUT 1.0*10^9/L to 7.0*10^9/L.

Exclusion criteria

Exclusion criteria: 1. Serious complications such as multiple organ failure. 2. T>40 degree C.

Design outcomes

Primary

MeasureTime frame
The maximum diameter of the target lymph node;—

Secondary

MeasureTime frame
blood;—

Contacts

Public ContactJin Ruhui

Nanjing Integrated Traditional and Western Medicine Hospital

jinruhui@126.com+86 15996283001

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026